ATS 2018 International Conference - Mobile

Phenotypic Characterization of Blood and Lung ILC2 in Asthmatics Undergoing Segmental Allergen Provocation [Board No. 422]

Location: Board no. 422

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Tuesday

May

22

2:15 PM

4:15 PM

Speaker(s)/Author(s)

Thomas Hochdorfer

PhD
AstraZeneca

Katerina Pardali

Bs, Ms
AstraZeneca

Meike Mueller

Ph.D.
Fraunhofer ITEM

Annemarie Hasselberg

Ph.D.
AstraZeneca

Anders Cavallin

MSc.
AstraZeneca;AstraZeneca Gothenburg

Jens M. Hohlfeld

M.D.
Fraunhofer Institute;Fraunhofer Institute for Toxicology and Experimental Medicine;Fraunhofer ITEM, Department of Respiratory Medicine, Hannover Medical School, Member of German Cente;Fraunhofer ITEM,

Carla Winkler

PhD
AstraZeneca

Outi Vaarala

M.D., Ph.D.
AstraZeneca;AstraZeneca RIA IMED Biotech Unit;Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden

Katrin Lueer

Ph.D.
ITEM

View Abstract

Phenotypic Characterization of Blood and Lung ILC2 in Asthmatics Undergoing Segmental Allergen Provocation

Parent Sessions

C101 - ASTHMA CLINICAL AND MECHANISTIC STUDIES...
05-22-2018 2:15 PM - 4:15 PM